Canton Strategic Holdings (CNTN) investor relations material

Executive summary

• Completed strategic shift to digital asset treasury management, focusing on Canton Coin (CC) and validator operations, with divestiture of the clinical-stage biotech business finalized in July 2026.

• Recorded first operating revenue from Super Validator and Locking-as-a-Service (LAAS), totaling $1.5 million for Q2 2026.

• Raised over $537 million in November 2025 and $53 million in January 2026 through private placements and direct offerings, supporting liquidity and digital asset strategy.

• Strengthened governance with the election of three new directors with expertise in financial markets and technology.

Financial highlights

• Total revenue for Q2 2026 was $1,495,859, compared to $0 in Q2 2025.

• Net loss for Q2 2026 was $19,254,826, or $(0.08) per share.

• Unrealized loss from digital asset holdings was $23,735,950 for Q2 2026, reflecting CC price declines.

• Adjusted EBITDA loss of $820,449 for Q2 2026, improved from a loss of $1,126,984 in Q2 2025.

• Cash and cash equivalents increased to $37.2 million as of June 30, 2026.

Outlook and guidance

• Management expects continued growth in CC holdings and LAAS revenue as validator operations and ecosystem participation expand.

• Super Validator active weight expected to grow thirty-fold by Q1 2028 as deliverables are met and approved.

• Sufficient liquidity is projected through at least June 2027, with flexibility to access additional capital via shelf registration and ATM programs.

• Remaining SV reward weight unlocks are anticipated through Q1 2028, contingent on milestone achievements.